131 related articles for article (PubMed ID: 38885438)
1. Potent, Selective Agonists for the Cannabinoid-like Orphan G Protein-Coupled Receptor GPR18: A Promising Drug Target for Cancer and Immunity.
Mahardhika AB; Załuski M; Schoeder CT; Boshta NM; Schabikowski J; Perri F; Łażewska D; Neumann A; Kremers S; Oneto A; Ressemann A; Latacz G; Namasivayam V; Kieć-Kononowicz K; Müller CE
J Med Chem; 2024 Jun; ():. PubMed ID: 38885438
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18.
Schoeder CT; Mahardhika AB; Drabczyńska A; Kieć-Kononowicz K; Müller CE
ACS Med Chem Lett; 2020 Oct; 11(10):2024-2031. PubMed ID: 33062188
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18.
Schoeder CT; Kaleta M; Mahardhika AB; Olejarz-Maciej A; Łażewska D; Kieć-Kononowicz K; Müller CE
Eur J Med Chem; 2018 Jul; 155():381-397. PubMed ID: 29902723
[TBL] [Abstract][Full Text] [Related]
4. Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18.
Neumann A; Engel V; Mahardhika AB; Schoeder CT; Namasivayam V; Kieć-Kononowicz K; Müller CE
Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365486
[TBL] [Abstract][Full Text] [Related]
5. Novel GPR18 Ligands in Rodent Pharmacological Tests: Effects on Mood, Pain, and Eating Disorders.
Frankowska M; Wydra K; Suder A; Zaniewska M; Gawliński D; Miszkiel J; Furgała-Wojas A; Sałat K; Filip M; Müller CE; Kieć-Kononowicz K; Kotańska M
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240392
[TBL] [Abstract][Full Text] [Related]
6. The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects.
Kotańska M; Kubacka M; Bednarski M; Nicosia N; Szafarz M; Jawień W; Müller CE; Kieć-Kononowicz K
Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451896
[TBL] [Abstract][Full Text] [Related]
7. Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold.
Rempel V; Volz N; Gläser F; Nieger M; Bräse S; Müller CE
J Med Chem; 2013 Jun; 56(11):4798-810. PubMed ID: 23679955
[TBL] [Abstract][Full Text] [Related]
8. Activation of GPR18 by cannabinoid compounds: a tale of biased agonism.
Console-Bram L; Brailoiu E; Brailoiu GC; Sharir H; Abood ME
Br J Pharmacol; 2014 Aug; 171(16):3908-17. PubMed ID: 24762058
[TBL] [Abstract][Full Text] [Related]
9. GPR18 and GPR55-related Ligands Serving as Antagonists or Agonists: Current Situation, Challenges and Perspectives.
Zhang L; Fang Y; Hang S; Wu W; Sheng R; Guo R
Med Chem; 2023; 19(9):838-847. PubMed ID: 37038675
[TBL] [Abstract][Full Text] [Related]
10. Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells.
McHugh D; Page J; Dunn E; Bradshaw HB
Br J Pharmacol; 2012 Apr; 165(8):2414-24. PubMed ID: 21595653
[TBL] [Abstract][Full Text] [Related]
11. A GPR18-based signalling system regulates IOP in murine eye.
Caldwell MD; Hu SS; Viswanathan S; Bradshaw H; Kelly ME; Straiker A
Br J Pharmacol; 2013 Jun; 169(4):834-43. PubMed ID: 23461720
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological evaluation of new constituents of "Spice": synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds.
Schoeder CT; Hess C; Madea B; Meiler J; Müller CE
Forensic Toxicol; 2018; 36(2):385-403. PubMed ID: 29963207
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and structure-activity relationships of diindolylmethane derivatives as cannabinoid CB
Mahardhika AB; Ressemann A; Kremers SE; Gregório Castanheira MS; Schoeder CT; Müller CE; Pillaiyar T
Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200493. PubMed ID: 36437108
[TBL] [Abstract][Full Text] [Related]
14. Novel selective agonist of GPR18, PSB-KK-1415 exerts potent anti-inflammatory and anti-nociceptive activities in animal models of intestinal inflammation and inflammatory pain.
Fabisiak A; Fabisiak N; Mokrowiecka A; Malecka-Panas E; Jacenik D; Kordek R; Zielińska M; Kieć-Kononowicz K; Fichna J
Neurogastroenterol Motil; 2021 Mar; 33(3):e14003. PubMed ID: 33058313
[TBL] [Abstract][Full Text] [Related]
15. GPR18-Mediated Relaxation of Human Isolated Pulmonary Arteries.
Kozłowska H; Malinowska B; Baranowska-Kuczko M; Kusaczuk M; Nesterowicz M; Kozłowski M; Müller CE; Kieć-Kononowicz K; Schlicker E
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163351
[TBL] [Abstract][Full Text] [Related]
16. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.
McHugh D; Hu SS; Rimmerman N; Juknat A; Vogel Z; Walker JM; Bradshaw HB
BMC Neurosci; 2010 Mar; 11():44. PubMed ID: 20346144
[TBL] [Abstract][Full Text] [Related]
17. RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB
Glenn NAK; Finlay DB; Carruthers ER; Mountjoy KG; Walker CS; Grimsey NL
Br J Pharmacol; 2024 Jul; 181(14):2212-2231. PubMed ID: 37085333
[TBL] [Abstract][Full Text] [Related]
18. 8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35.
Funke M; Thimm D; Schiedel AC; Müller CE
J Med Chem; 2013 Jun; 56(12):5182-97. PubMed ID: 23713606
[TBL] [Abstract][Full Text] [Related]
19. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.
Kapur A; Zhao P; Sharir H; Bai Y; Caron MG; Barak LS; Abood ME
J Biol Chem; 2009 Oct; 284(43):29817-27. PubMed ID: 19723626
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice.
Hess C; Schoeder CT; Pillaiyar T; Madea B; Müller CE
Forensic Toxicol; 2016; 34():329-343. PubMed ID: 27429655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
